Dashboard
Manage Tickers

AKYAAkoya Biosciences, Inc.

Nasdaq akoyabio.com


$ 3.86 $ 0.06 (1.58 %)    

Monday, 29-Apr-2024 15:59:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.07 $ -1.19 (-0.28 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 213.73 $ -0.23 (-0.11 %)
$ 3.86
$ 3.81
$ 0.00 x 0
$ 3.87 x 100
$ 3.81 - $ 3.87
$ 3.04 - $ 8.80
68,178
na
171.52M
$ 1.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-04-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-07-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-14-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-19-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-10
JP Morgan Maintains Overweight on Akoya Bi...
03/06/2024 16:06:20

JP Morgan analyst Tycho Peterson maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target fro...

ubs-maintains-buy-on-akoya-biosciences-raises-price-target-to-75
UBS Maintains Buy on Akoya Biosciences, Ra...
03/05/2024 14:44:40

UBS analyst John Sourbeer maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and raises the price target from $7 to $7.5.

canaccord-genuity-reiterates-buy-on-akoya-biosciences-maintains-10-price-target
Canaccord Genuity Reiterates Buy on Akoya ...
03/05/2024 13:58:22

Canaccord Genuity analyst Kyle Mikson reiterates Akoya Biosciences (NASDAQ:AKYA) with a Buy and maintains $10 price target.

akoya-biosciences-sees-fy24-revenue-114m-118m-vs-11738m-est
Akoya Biosciences Sees FY24 Revenue $114M-...
03/04/2024 21:40:32

2024 Financial OutlookThe Company, based on its current plans and initiatives, expects full year 2024 revenue guidance range of...

recap-akoya-biosciences-q4-earnings
Recap: Akoya Biosciences Q4 Earnings
03/04/2024 21:15:10

akoya-biosciences-q4-2023-gaap-eps-022-beats-028-estimate-sales-2649m-beat-2589m-estimate
Akoya Biosciences Q4 2023 GAAP EPS $(0.22)...
03/04/2024 21:15:05

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0...

earnings-scheduled-for-march-4-2024
Earnings Scheduled For March 4, 2024
03/04/2024 09:53:45

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

earnings-outlook-for-akoya-biosciences
Earnings Outlook For Akoya Biosciences
03/01/2024 15:01:18

akoya-biosciences-announces-preliminary-financial-results-for-q4-and-fy23-and-provides-2024-outlook-sees-q4-revenue-255m-265m-vs-2628m-est-fy23-revenue-956m-966m-vs-966m-est-expects-fy24-revenue-to-grow-20
Akoya Biosciences Announces Preliminary Fi...
01/07/2024 20:18:14

Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced preliminary unaudited re...

akoya-biosciences-announced-earlier-sunday-it-deployed-the-maxfuse-algorithm-co-developed-by-dr-garry-nolan-and-his-laboratory-at-stanford-university-for-multiomic-integration-of-spatial-and-single-cell-data-on-the-enable-medicine-platform
Akoya Biosciences Announced Earlier Sunday...
01/07/2024 16:06:45

Akoya Biosciences, Inc., (NASDAQ:AKYA), The Spatial Biology Company®, in collaboration with Enable Medicine, a leading provider...

Core News & Articles
Akoya Biosciences And Thermo Fisher Scient...
01/07/2024 16:05:11

Akoya Biosciences, Inc., (NASDAQ:AKYA), The Spatial Biology Company®, today announced that it has entered into a license and di...

analyst-ratings-for-akoya-biosciences
Analyst Ratings for Akoya Biosciences
12/14/2023 14:00:39

guggenheim-initiates-coverage-on-akoya-biosciences-with-neutral-rating
Guggenheim Initiates Coverage On Akoya Bio...
12/14/2023 11:23:37

Guggenheim analyst Subbu Nambi initiates coverage on Akoya Biosciences (NASDAQ:AKYA) with a Neutral rating.

piper-sandler-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-8
Piper Sandler Maintains Overweight on Akoy...
11/13/2023 21:09:50

Piper Sandler analyst David Westenberg maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price targ...

expert-ratings-for-akoya-biosciences
Expert Ratings for Akoya Biosciences
11/13/2023 15:00:25

stephens--co-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-9
Stephens & Co. Maintains Overweight on Ako...
11/13/2023 14:13:16

Stephens & Co. analyst Mason Carrico maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price ta...

recap-akoya-biosciences-q3-earnings
Recap: Akoya Biosciences Q3 Earnings
11/08/2023 21:45:28

akoya-biosciences-q3-eps-026-beats-037-estimate-sales-2521m-beat-2454m-estimate
Akoya Biosciences Q3 EPS $(0.26) Beats $(0...
11/08/2023 21:42:28

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0...

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

akoya-biosciences-to-showcase-new-spatial-biology-20-solutions-and-spatial-phenotyping-data-at-sitc-2023
Akoya Biosciences To Showcase New Spatial ...
10/31/2023 13:19:49

Spatial Biology 2.0 solutions enable discovery and translational workflows at an unprecedented speed and scale Global network o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION